Royalty Pharma Plc (RPRX) Institutional Ownership Changes & 13F Activity

Royalty Pharma Plc (RPRX). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings. This page analyzes institutional buying and selling activity, new holdings, and sold-out positions among tracked filers. Notable filers include Renaissance Technologies LLC, Torray Fund, Dorsey Asset Management, Sequoia Financial Advisors, and Viking Global Investors.

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q1 2026Renaissance Technologies LLCBuy780,747790,937$37,941,248
Q1 2026Torray FundSell-98,930645,425$30,961,051
Q1 2026Dorsey Asset ManagementBuy17,1012,276,570$109,207,063
Q1 2026Sequoia Financial AdvisorsBuy3,98115,670$751,699
Q4 2025Dorsey Asset ManagementSell-90,9802,259,469$87,305,882
Q4 2025Torray FundBuy41,472744,355$28,761,889
Q4 2025Sequoia Financial AdvisorsBuy1,85911,689$451,655
Q3 2025Dorsey Asset ManagementBuy2,350,4492,350,449$82,923,841
Q3 2025Torray FundBuy14,107702,883$24,797,712
Q3 2025Sequoia Financial AdvisorsBuy3,3609,830$346,815
Q2 2025Viking Global InvestorsSell-7,966,4792,597,460$93,586,484
Q2 2025Torray FundSell-173,242688,776$24,816,599
Q2 2025Sequoia Financial AdvisorsBuy6,4706,470$233,119
Q1 2025Viking Global InvestorsSell-1,643,94610,563,939$328,855,421
Q1 2025Torray FundBuy178,011862,018$26,834,620
Q4 2024Torray FundSell-173,912684,007$17,449,019
Q4 2024Viking Global InvestorsBuy113,86412,207,885$311,423,146
Q3 2024Torray FundBuy164,361857,919$24,270,529
Q3 2024Viking Global InvestorsBuy123,96312,094,021$342,139,854
Q2 2024Torray FundBuy686,181693,558$18,289,124
Q2 2024Viking Global InvestorsBuy484,51111,970,058$315,650,429
Q1 2024Viking Global InvestorsBuy1,398,13011,485,547$348,816,062
Q1 2024Torray FundSell-498,3637,377$20,349,722
Q1 2024Renaissance Technologies LLCSell-473,01010,190$309
Q4 2023Viking Global InvestorsBuy623,21610,087,417$283,355,544
Q4 2023Torray FundBuy93,107505,740$14,206,237
Q3 2023Viking Global InvestorsSell-386,7319,464,201$256,858,415
Q3 2023Renaissance Technologies LLCSell-287,500483,200$13,114
Q3 2023Torray FundSell-1,182412,633$11,198,860
Q2 2023Viking Global InvestorsSell-1,353,3179,850,932$302,817,650

Frequently asked questions about RPRX activity

  • Which institutional owners are buying RPRX?

    Institutional owners buying RPRX include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in RPRX activity?

    "Buy" means an investor increased their reported position in RPRX compared to the prior reporting period. This reflects growing exposure to Royalty Pharma Plc (RPRX) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in RPRX increasing?

    Institutional interest in RPRX can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.

Related RPRX Institutional Insights